Search hospitals > Georgia > Augusta
Augusta University Medical Center
Claim this profileAugusta, Georgia 30912
Global Leader in Skin Cancer
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Ovarian Cancer
Conducts research for Relapse
Conducts research for Uterine Tumors
247 reported clinical trials
32 medical researchers
Summary
Augusta University Medical Center is a medical facility located in Augusta, Georgia. This center is recognized for care of Skin Cancer, T-Lymphoblastic Leukemia/Lymphoma, Ovarian Cancer, Relapse, Uterine Tumors and other specialties. Augusta University Medical Center is involved with conducting 247 clinical trials across 951 conditions. There are 32 research doctors associated with this hospital, such as Sharad Ghamande, Colleen H. McDonough, Jorge Cortes, MD, and Vamsi Kota, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage I
Stage III
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderStage II
CD5 positive
Philadelphia chromosome positive
Top PIs
Sharad GhamandeAugusta University Medical Center2 years of reported clinical research
Expert in Skin Cancer
Expert in Stomach Cancer
72 reported clinical trials
150 drugs studied
Colleen H. McDonoughAugusta University Medical Center5 years of reported clinical research
Studies Uterine Tumors
Studies T-Lymphoblastic Leukemia/Lymphoma
16 reported clinical trials
56 drugs studied
Jorge Cortes, MDGeorgia Cancer Center at Augusta University6 years of reported clinical research
Expert in T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
14 reported clinical trials
19 drugs studied
Vamsi Kota, MDAugusta University Medical Center1 year of reported clinical research
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Acute Myeloid Leukemia
11 reported clinical trials
43 drugs studied
Clinical Trials running at Augusta University Medical Center
Skin Cancer
Lung Cancer
Ovarian Cancer
Uterine Cancer
Acute Myeloid Leukemia
Non-Small Cell Lung Cancer
Endometrial Cancer
Lymphoma
Testicular cancer
Stroke
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
MRI Monitoring vs. Preventive Brain Radiation
for Small Cell Lung Cancer
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.
Recruiting2 awards Phase 322 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Augusta University Medical Center?
Augusta University Medical Center is a medical facility located in Augusta, Georgia. This center is recognized for care of Skin Cancer, T-Lymphoblastic Leukemia/Lymphoma, Ovarian Cancer, Relapse, Uterine Tumors and other specialties. Augusta University Medical Center is involved with conducting 247 clinical trials across 951 conditions. There are 32 research doctors associated with this hospital, such as Sharad Ghamande, Colleen H. McDonough, Jorge Cortes, MD, and Vamsi Kota, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.